recurrent ovarian epithelial cancer

Showing 1 - 25 of 43

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Brenner Tumor, Malignant Ascites, Malignant Pleural Effusion Trial in United States (metformin HCl, , Chemotherapy)

Suspended
  • Brenner Tumor
  • +27 more
  • metformin hydrochloride
  • +2 more
  • Birmingham, Alabama
  • +9 more
May 16, 2022

Fallopian Tube Cancer, Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer Trial in Duarte, Pasadena

Active, not recruiting
  • Fallopian Tube Cancer
  • +2 more
  • Duarte, California
  • +1 more
Mar 17, 2022

Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer Trial in

Completed
  • Recurrent Fallopian Tube Cancer
  • +23 more
  • ALVAC(2)-NY-ESO-1 (M)/TRICOM vaccine
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Mar 25, 2020

Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer Trial in

Completed
  • Recurrent Fallopian Tube Cancer
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Jul 31, 2019

Fallopian Tube Cancer, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer Trial in Philadelphia (tamoxifen

Completed
  • Fallopian Tube Cancer
  • +4 more
  • tamoxifen citrate
  • +2 more
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Jul 22, 2019

Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer Trial in Philadelphia (bortezomib, laboratory biomarker

Completed
  • Primary Peritoneal Cavity Cancer
  • Recurrent Ovarian Epithelial Cancer
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Jul 22, 2019

Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer Trial in Philadelphia (lapatinib ditosylate, laboratory

Completed
  • Primary Peritoneal Cavity Cancer
  • Recurrent Ovarian Epithelial Cancer
  • lapatinib ditosylate
  • laboratory biomarker analysis
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Jul 22, 2019

Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer Trial in Philadelphia

Completed
  • Primary Peritoneal Cavity Cancer
  • +2 more
  • bevacizumab
  • laboratory biomarker analysis
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Jul 22, 2019

Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer Trial in Philadelphia (ixabepilone)

Completed
  • Primary Peritoneal Cavity Cancer
  • Recurrent Ovarian Epithelial Cancer
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Jul 22, 2019

Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer Trial in Philadelphia (irofulven)

Completed
  • Primary Peritoneal Cavity Cancer
  • Recurrent Ovarian Epithelial Cancer
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Jul 22, 2019

Fallopian Tube Cancer, Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer Trial in Philadelphia (everolimus,

Completed
  • Fallopian Tube Cancer
  • +2 more
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Jul 9, 2019

Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma Trial in Seattle (biological,

Completed
  • Fallopian Tube Cancer
  • +10 more
  • denileukin diftitox
  • +4 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
May 13, 2019

Ovarian Papillary Serous Carcinoma, Ovarian Serous Cystadenocarcinoma, Recurrent Fallopian Tube Cancer Trial in Philadelphia

Withdrawn
  • Ovarian Papillary Serous Carcinoma
  • +5 more
  • metformin hydrochloride
  • +3 more
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Feb 18, 2019

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute

Terminated
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +13 more
  • ipilimumab
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Sep 4, 2018

Advanced Malignant Mesothelioma, Carcinoma of the Appendix, Ovarian Sarcoma Trial in Winston-Salem (HIPEC Orientation,

Completed
  • Advanced Malignant Mesothelioma
  • +15 more
  • HIPEC Orientation
  • +2 more
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Jul 2, 2018

Recurrent Ovarian Epithelial Cancer, Recurrent Fallopian Tube Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Duarte

Completed
  • Recurrent Ovarian Epithelial Cancer
  • +2 more
  • modified vaccinia virus ankara vaccine expressing p53
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Apr 26, 2018

Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma Trial in Seattle (biological, drug, other)

Completed
  • Brenner Tumor
  • +11 more
  • sargramostim
  • +3 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Jul 24, 2017

Recurrent Ovarian Epithelial Cancer, Recurrent Ovarian Germ Cell Tumor, Malignant Tumor of Peritoneum Trial in Stanford

Terminated
  • Recurrent Ovarian Epithelial Cancer
  • +4 more
  • stereotactic body radiation therapy
  • +4 more
  • Stanford, California
    Stanford University
Apr 26, 2017

Fallopian Tube Cancer, Female Reproductive Cancer, Recurrent Breast Cancer Trial in United States (ixabepilone, pegylated

Completed
  • Fallopian Tube Cancer
  • +6 more
  • Farmington, Connecticut
  • +4 more
Feb 11, 2016

Recurrent Ovarian Epithelial Cancer Trial in Bronx, New York (oxaliplatin, topotecan)

Terminated
  • Recurrent Ovarian Epithelial Cancer
  • Bronx, New York
  • +1 more
Oct 27, 2015

Anxiety Disorder, Depression, Fatigue Trial in Columbus (other, procedure, behavioral)

Completed
  • Anxiety Disorder
  • +19 more
  • questionnaire administration
  • +5 more
  • Columbus, Ohio
    Ohio State University Medical Center
Oct 8, 2015

HER2-positive Breast Cancer, Recurrent Breast Cancer, Recurrent NSCLC Trial in Seattle (drug, biological, other)

Completed
  • HER2-positive Breast Cancer
  • +8 more
  • ex vivo-expanded HER2-specific T cells
  • +4 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Nov 7, 2014

Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer, Stage IIIA Ovarian Epithelial Cancer Trial in

Completed
  • Recurrent Ovarian Epithelial Cancer
  • +9 more
  • Rochester, Minnesota
    Mayo Clinic
May 6, 2014